Long-term follow-up for incident cirrhosis among pediatric cancer survivors with hepatitis C virus infection

Journal of Clinical Virology

Volumn 71, Issue , 2015, Pages 18-21

  Stallings Smith, Sericea ^a   Krull, Kevin R ^a   Brinkman, Tara M ^a   Hudson, Melissa M ^a   Ojha, Rohit P ^a  

^a ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

Author keywords

Epidemiology; Hepatitis C virus; Infection; Late effects; Liver disease; Pediatric cancer

Indexed keywords

ANTIVIRUS AGENT;

ADULT; ANTIVIRAL THERAPY; ARTICLE; CANCER PATIENT; CANCER SURVIVAL; CANCER SURVIVOR; CENTRAL NERVOUS SYSTEM TUMOR; CHILD; CHILDHOOD CANCER; DIAGNOSTIC IMAGING; FEMALE; FOLLOW UP; HEPATITIS C; HEPATITIS C VIRUS GENOTYPE 1; HUMAN; HUMAN TISSUE; INCIDENCE; LEUKEMIA; LIVER BIOPSY; LIVER CIRRHOSIS; LYMPHOMA; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PRESCHOOL CHILD; PRIORITY JOURNAL; SEX DIFFERENCE; SURVIVAL TIME; ADOLESCENT; ADVERSE EFFECTS; BLOOD TRANSFUSION; CHRONIC HEPATITIS C; COMPLICATION; LONGITUDINAL STUDY; NEOPLASMS; SURVIVOR; YOUNG ADULT;

ADOLESCENT; ADULT; BLOOD TRANSFUSION; CHILD; CHILD, PRESCHOOL; FEMALE; HEPATITIS C, CHRONIC; HUMANS; INCIDENCE; LIVER CIRRHOSIS; LONGITUDINAL STUDIES; MALE; NEOPLASMS; SEX FACTORS; SURVIVORS; YOUNG ADULT;

EID: 84941561198     PISSN: 13866532     EISSN: 18735967     Source Type: Journal    
DOI: 10.1016/j.jcv.2015.07.306     Document Type: Article

References (22)

1. Shepard C.W., Finelli L., Alter M.J. Global epidemiology of hepatitis C virus infection. Lancet Infect. Dis. 2005, 5(9):558-567.
2. Ghany M.G., Strader D.B., Thomas D.L., et al. Diagnosis, management, and treatment of hepatitis C: an update. Hepatology 2009, 49(4):1335-1374.
3. Paul I.M., Sanders J., Ruggiero F., et al. Chronic hepatitis C virus infections in leukemia survivors: prevalence, viral load, and severity of liver disease. Blood 1999, 93(11):3672-3677.
4. Rustgi V.K. The epidemiology of hepatitis C infection in the United States. J. Gastroenterol. 2007, 42(7):513-521.
5. Baden R., Rockstroh J.K., Buti M. Natural history and management of hepatitis C: does sex play a role?. J. Infect. Dis. 2014, 209(Suppl 3):S81-5.
6. Pineda J.A., Garcia-Garcia J.A., Aguilar-Guisado M., et al. Clinical progression of hepatitis C virus-related chronic liver disease in human immunodeficiency virus-infected patients undergoing highly active antiretroviral therapy. Hepatology 2007, 46(3):622-630.
7. Castellino S., Lensing S., Riely C., et al. The epidemiology of chronic hepatitis C infection in survivors of childhood cancer: an update of the St Jude Children's Research Hospital hepatitis C seropositive cohort. Blood 2004, 103(7):2460-2466.
8. Desmet V.J., Gerber M., Hoofnagle J.H., et al. Classification of chronic hepatitis: diagnosis, grading and staging. Hepatology 1994, 19(6):1513-1520.
9. Lau B., Cole S.R., Gange S.J. Competing risk regression models for epidemiologic data. Am. J. Epidemiol. 2009, 170(2):244-256.
10. Cologne J., Hsu W.L., Abbott R.D., et al. Proportional hazards regression in epidemiologic follow-up studies: an intuitive consideration of primary time scale. Epidemiology 2012, 23(4):565-573.
11. Pradat P., Voirin N., Tillmann H.L., et al. Progression to cirrhosis in hepatitis C patients: an age-dependent process. Liver Int. 2007, 27(3):335-339.
12. Ojha R.P., Jackson B.E., Tota J.E., et al. Younger age distribution of cervical cancer incidence among survivors of pediatric and young adult cancers. Gynecol. Oncol. 2014, 134(2):309-313.
13. Hudson M.M., Ness K.K., Gurney J.G., et al. Clinical ascertainment of health outcomes among adults treated for childhood cancer. JAMA 2013, 309(22):2371-2381.
14. Ness K.K., Krull K.R., Jones K.E., et al. Physiologic frailty as a sign of accelerated aging among adult survivors of childhood cancer: a report from the St Jude lifetime cohort study. J. Clin. Oncol. 2013, 31(36):4496-4503.
15. El-Raziky M.S., Halawa E.F., Draz I.H., et al. Natural history and response to treatment of HCV infection among Egyptian survivors of childhood malignancy. Pediatr. Hematol. Oncol. 2015, 32(2):138-145.
16. Fioredda F., Moser A., Bertoluzzo L., et al. Natural course of HCV infection in childhood cancer survivors. Support Care Cancer 2009, 18(11):1413-1420.
17. Cesaro S., Bortolotti F., Petris M.G., et al. An updated follow-up of chronic hepatitis C after three decades of observation in pediatric patients cured of malignancy. Pediatr Blood Cancer 2010, 55:108-112.
18. Rothman K., Greenland S., Lash T. Modern Epidemiology 2008, Lippincott Williams & Wilkins, Philadelphia, PA. 3rd ed.
19. Grambauer N., Schumacher M., Dettenkofer M., et al. Incidence densities in a competing events analysis. Am. J. Epidemiol. 2010, 172(9):1077-1084.
20. Martin J., Khatri G., Gopal P., et al. Accuracy of ultrasound and noninvasive markers of fibrosis to identify patients with cirrhosis. Dig. Dis. Sci. 2015, 10.1007/s10620-015-3531-1.
21. Lansdale M., Castellino S., Marina N., et al. Knowledge of hepatitis C virus screening in long-term pediatric cancer survivors: a report from the childhood cancer survivor study. Cancer 2010, 116(4):974-982.
22. Fernandez M., Trepo E., Degre D., et al. Transient elastography using fibroscan is the most reliable noninvasive method for the diagnosis of advanced fibrosis and cirrhosis in alcoholic liver disease. Eur. J. Gastroenterol. Hepatol. 2015, 10.1097/meg.0000000000000392.